摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(Diethylamino)-3-oxopropanoyl chloride | 87039-69-8

中文名称
——
中文别名
——
英文名称
3-(Diethylamino)-3-oxopropanoyl chloride
英文别名
——
3-(Diethylamino)-3-oxopropanoyl chloride化学式
CAS
87039-69-8
化学式
C7H12ClNO2
mdl
——
分子量
177.631
InChiKey
CCOLSDOBEPIOGP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    246.5±23.0 °C(Predicted)
  • 密度:
    1.131±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    11
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    37.4
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:5e2f022d5390404e74c5786f34a3943d
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Disoxaril-related 3-(diethylamino)-5-phenylisoxazoles
    摘要:
    Previous research has shown that 3-(dialkylamino)-5-phenylisoxazoles possessing a compact structure were active against HRV-2 and, consequently, presented a type B activity. In this paper, 3-(diethylamino)-5-phenylisoxazoles, which are structurally more elongated and related to Disoxaril, were synthesized in view to attempt type A activity against HRV-14. Unfortunately, all tested compounds were devoid of activity against HRV-14 (and HIV-1) of exhibited great toxicity. (C) 2000 Elsevier Science S.A. All rights reserved.
    DOI:
    10.1016/s0014-827x(00)00002-1
  • 作为产物:
    描述:
    N,N-diethylmalonamic acid五氯化磷 作用下, 以 四氢呋喃 为溶剂, 反应 3.0h, 生成 3-(Diethylamino)-3-oxopropanoyl chloride
    参考文献:
    名称:
    1,2-Fused pyrimidines VII. 3-(Dialkylamino)-1H-pyrimido[1,2-a]quinolin-1-ones and 2-(dialkylamino)-4H-pyrimido[2,1-a]isoquinolin-4-ones as antiplatelet compounds
    摘要:
    A number of 3-(dialkylamino)-1H-pyrimido[1,2-a]quinolin-1 ones 3 and 2-(dialkylamino)-4H-pyrimido [2,1-a]isoquinolin-4-ones 4 were prepared by treating the corresponding chloro derivatives with an excess of dialkylamines. The highest in vitro antiplatelet activity was obtained when the dialkylamino substituent was 1-piperazinyl (compounds 3g and 4e). The novel 2-(1-piperazinyl)-4H-pyrido[ ,2-a]pyrimidin-4-one 2a was also prepared by an analogous procedure, which resulted in the most active compound towards all the platelet aggregation inducers used (ADP, collagen, A 23187). Moreover, some examples of 1-(dialkylamino)-3H pyrimido[l,2-a]quinolin-3-ones 5 and 4-(dialkylamino)-2H-pyrimido[2,1-a]isoquinolin-2-ones 6 were also obtained (together with negligible or lower amounts of the corresponding isomers 3 and 4, respectively) from the cyclocondensation of the appropriate ethyl N,N-dialkylmalonamate/phosphorus oxychloride reagents 13 with 2-aminoquinoline or 1-aminoisoquinoline. These;latter compounds showed a rather low antiplatelet activity.
    DOI:
    10.1016/0223-5234(96)88206-7
点击查看最新优质反应信息

文献信息

  • Cleavage of silicon-nitrogen bonds by acid chlorides: an unusual synthetic route to amides
    作者:James R. Bowser、Pamela J. Williams、Kenneth Kurz
    DOI:10.1021/jo00170a050
    日期:1983.11
  • BOWSER, J. R.;WILLIAMS, P. J.;KURZ, K., J. ORG. CHEM., 1983, 48, N 22, 4111-4113
    作者:BOWSER, J. R.、WILLIAMS, P. J.、KURZ, K.
    DOI:——
    日期:——
  • 1,2-Fused pyrimidines VII. 3-(Dialkylamino)-1H-pyrimido[1,2-a]quinolin-1-ones and 2-(dialkylamino)-4H-pyrimido[2,1-a]isoquinolin-4-ones as antiplatelet compounds
    作者:M Di Braccio、G Roma、G Leoncini
    DOI:10.1016/0223-5234(96)88206-7
    日期:1995.1
    A number of 3-(dialkylamino)-1H-pyrimido[1,2-a]quinolin-1 ones 3 and 2-(dialkylamino)-4H-pyrimido [2,1-a]isoquinolin-4-ones 4 were prepared by treating the corresponding chloro derivatives with an excess of dialkylamines. The highest in vitro antiplatelet activity was obtained when the dialkylamino substituent was 1-piperazinyl (compounds 3g and 4e). The novel 2-(1-piperazinyl)-4H-pyrido[ ,2-a]pyrimidin-4-one 2a was also prepared by an analogous procedure, which resulted in the most active compound towards all the platelet aggregation inducers used (ADP, collagen, A 23187). Moreover, some examples of 1-(dialkylamino)-3H pyrimido[l,2-a]quinolin-3-ones 5 and 4-(dialkylamino)-2H-pyrimido[2,1-a]isoquinolin-2-ones 6 were also obtained (together with negligible or lower amounts of the corresponding isomers 3 and 4, respectively) from the cyclocondensation of the appropriate ethyl N,N-dialkylmalonamate/phosphorus oxychloride reagents 13 with 2-aminoquinoline or 1-aminoisoquinoline. These;latter compounds showed a rather low antiplatelet activity.
  • Disoxaril-related 3-(diethylamino)-5-phenylisoxazoles
    作者:Mauro Mazzei、Ramona Dondero、Bernardetta Ledda、Francesca Demontis、Laura Vargiu
    DOI:10.1016/s0014-827x(00)00002-1
    日期:2000.2
    Previous research has shown that 3-(dialkylamino)-5-phenylisoxazoles possessing a compact structure were active against HRV-2 and, consequently, presented a type B activity. In this paper, 3-(diethylamino)-5-phenylisoxazoles, which are structurally more elongated and related to Disoxaril, were synthesized in view to attempt type A activity against HRV-14. Unfortunately, all tested compounds were devoid of activity against HRV-14 (and HIV-1) of exhibited great toxicity. (C) 2000 Elsevier Science S.A. All rights reserved.
查看更多